TY - JOUR
T1 - Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine
AU - Paunesku, David
AU - Paunesku, Tatjana
AU - Wahl, Andrew
AU - Kataoka, Yasushi
AU - Murley, Jeffrey
AU - Grdina, David J.
AU - Woloschak, Gayle E.
N1 - Funding Information:
This work was supported by US DOE grants DE-FG02-04ER63920 and DE-FG02-05ER64086; initial development of the database website janus. northwestern.edu was sponsored in part by US DOE grant DE-FG02-05ER64100/A000. We gratefully acknowledge the statistical advice of Dr Alfred Rademaker, Northwestern University.
PY - 2008
Y1 - 2008
N2 - Purpose: To determine the effects of Amifostine or WR-151327 on the incidence of lethal and non-lethal toxicities in a large cohort of mice exposed to γ-ray or fission-spectrum neutron radiation. Methods: To analyze data from 4000 B6CF1 mice which received a single whole body irradiation (WBI) with 206 cGy or 417 cGy cobalt-60 gamma rays or 10 cGy or 40 cGy of fission-spectrum neutrons (average energy 0.85 MeV) produced by the Janus reactor at Argonne National Laboratory. In the neutron cohort, Amifostine, WR-151327, saline or nothing was injected once, intraperitoneally, 30 minutes before irradiation. In the cobalt-60 cohort, WR-151327 was omitted from the same protocol. At the time of natural death, tissue toxicities found in these mice were recorded, and these records were analyzed. While all previous studies focused on the modulation of life shortening effects of WBI by Amifostine, in this study we calculated changes in the frequencies of 59 tissue toxicities and changes in the total number of toxicities per animal. Results: Amifostine protected against specific non-tumor pathological complications (67% of the non-tumor toxicities induced by gamma irradiation, 31% of the neutron induced specific toxicities), as well as specific tumors (56% of the tumor toxicities induced by gamma irradiation, 25% of the neutron induced tumors). Amifostine also reduced the total number of toxicities per animal for both genders in the gamma ray exposed mice and in males in the neutron exposed mice. Conclusions: Amifostine was protective against many, but not all, tissue toxicities caused by WBI gamma and neutron irradiation.
AB - Purpose: To determine the effects of Amifostine or WR-151327 on the incidence of lethal and non-lethal toxicities in a large cohort of mice exposed to γ-ray or fission-spectrum neutron radiation. Methods: To analyze data from 4000 B6CF1 mice which received a single whole body irradiation (WBI) with 206 cGy or 417 cGy cobalt-60 gamma rays or 10 cGy or 40 cGy of fission-spectrum neutrons (average energy 0.85 MeV) produced by the Janus reactor at Argonne National Laboratory. In the neutron cohort, Amifostine, WR-151327, saline or nothing was injected once, intraperitoneally, 30 minutes before irradiation. In the cobalt-60 cohort, WR-151327 was omitted from the same protocol. At the time of natural death, tissue toxicities found in these mice were recorded, and these records were analyzed. While all previous studies focused on the modulation of life shortening effects of WBI by Amifostine, in this study we calculated changes in the frequencies of 59 tissue toxicities and changes in the total number of toxicities per animal. Results: Amifostine protected against specific non-tumor pathological complications (67% of the non-tumor toxicities induced by gamma irradiation, 31% of the neutron induced specific toxicities), as well as specific tumors (56% of the tumor toxicities induced by gamma irradiation, 25% of the neutron induced tumors). Amifostine also reduced the total number of toxicities per animal for both genders in the gamma ray exposed mice and in males in the neutron exposed mice. Conclusions: Amifostine was protective against many, but not all, tissue toxicities caused by WBI gamma and neutron irradiation.
KW - Amifostine
KW - Fission neutron and gamma-ray irradiation
KW - Late tissue toxicity
UR - http://www.scopus.com/inward/record.url?scp=48249127986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48249127986&partnerID=8YFLogxK
U2 - 10.1080/09553000802241762
DO - 10.1080/09553000802241762
M3 - Article
C2 - 18661379
AN - SCOPUS:48249127986
SN - 0955-3002
VL - 84
SP - 623
EP - 634
JO - International Journal of Radiation Biology
JF - International Journal of Radiation Biology
IS - 8
ER -